Tests for Exocrine Pancreatic Function
The fecal elastase test is the most appropriate initial test for evaluating exocrine pancreatic function and must be performed on a semi-solid or solid stool specimen. 1
Diagnostic Testing Algorithm
First-Line Test: Fecal Elastase-1 (FE-1)
The fecal elastase test serves as the primary diagnostic tool because it is noninvasive, relatively inexpensive, and simple to perform 1. This test measures pancreatic enzyme levels indirectly through stool analysis.
Interpretation criteria:
- FE-1 <100 mg/g of stool: Provides good evidence of exocrine pancreatic insufficiency (EPI)
- FE-1 100-200 mg/g: Indeterminate for EPI
- FE-1 >200 mg/g: Normal pancreatic function 1
Critical technical requirement: The specimen must be semi-solid or solid stool. Liquid or watery stool samples will yield falsely low results and should not be used 1.
Important advantage: Fecal elastase testing can be performed while patients are already on pancreatic enzyme replacement therapy (PERT), unlike some other tests 1. This allows for diagnosis without interrupting treatment.
Tests That Are NOT Recommended for Routine Use
Fecal fat testing is rarely needed in clinical practice 1. When performed, it must be done while the patient is on a high-fat diet. Quantitative 72-hour fecal fat collection is generally impractical for routine clinical use, though it remains the gold standard for confirming steatorrhea 1.
Therapeutic trial of pancreatic enzymes is unreliable for EPI diagnosis and should not be used as a diagnostic test 1.
Cross-sectional imaging (CT scan, MRI, endoscopic ultrasound) cannot identify EPI itself, though these modalities play an important role in diagnosing the underlying pancreatic disease causing EPI 1.
Advanced Testing Options (Limited Availability)
Breath tests and direct pancreatic function tests show promise but are not widely available in the United States 1. The ¹³C-labeled mixed triglyceride breath test has been optimized and validated for EPI diagnosis and evaluating PERT efficacy 2, but commercial availability remains limited.
Endoscopic pancreatic function testing (ePFT) represents the most accurate direct measurement of pancreatic secretion 3, 4. This involves:
- Endoscopic stimulation of the pancreas
- Aspiration of pancreatic secretions for 30-60 minutes
- Analysis of bicarbonate concentration and pancreatic digestive enzymes
However, ePFT is invasive, time-consuming, burdensome to patients, and available only at specialized centers 1. It is primarily used for diagnosing early-stage chronic pancreatitis rather than routine EPI diagnosis 1.
Secretin-enhanced magnetic resonance cholangiopancreatography (sMRCP) is emerging as a promising noninvasive modality, particularly in pediatric patients 5. Patients with high pancreatic enzyme activities demonstrate larger pancreatic diameter, greater parenchyma volume, and higher post-secretin enteric fluid volume on sMRCP 5.
Clinical Context for Testing
Testing should be pursued when EPI is suspected based on:
High-risk conditions:
- Chronic pancreatitis
- Relapsing acute pancreatitis
- Pancreatic ductal adenocarcinoma
- Cystic fibrosis
- Previous pancreatic surgery 1
Moderate-risk conditions:
- Duodenal diseases (celiac disease, Crohn's disease)
- Previous intestinal surgery
- Long-standing diabetes mellitus
- Hypersecretory states (Zollinger-Ellison syndrome) 1
Clinical features suggesting EPI:
- Steatorrhea with or without diarrhea
- Weight loss
- Bloating and excessive flatulence
- Fat-soluble vitamin deficiencies
- Protein-calorie malnutrition 1
Common Pitfalls to Avoid
Do not use liquid stool specimens for fecal elastase testing—this is the most common technical error leading to false-positive results 1.
Do not rely on serum pancreatic enzyme levels (such as trypsin) as these are unreliable if the patient has ongoing pancreatic inflammation 1.
Do not use imaging alone to diagnose EPI. While CT, MRI, and EUS are excellent for identifying structural pancreatic disease, they cannot determine functional pancreatic insufficiency 1.
Do not repeat fecal elastase measurements to assess treatment response—this is not helpful as PERT does not alter FE-1 test results 1.
Why This Matters for Patient Outcomes
Untreated EPI results in complications related to fat malabsorption and malnutrition, having a negative impact on quality of life 1. Early and accurate diagnosis allows for timely initiation of PERT, which prevents these complications and improves nutritional status, weight gain, and overall quality of life 1.